Application 209905
- Type
- NDA
- Sponsor
- ARBOR PHARMS LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EVEKEO ODT | AMPHETAMINE SULFATE | TABLET, ORALLY DISINTEGRATING;ORAL | 5MG | Yes | No |
| 002 | EVEKEO ODT | AMPHETAMINE SULFATE | TABLET, ORALLY DISINTEGRATING;ORAL | 10MG | Yes | No |
| 003 | EVEKEO ODT | AMPHETAMINE SULFATE | TABLET, ORALLY DISINTEGRATING;ORAL | 15MG | Yes | No |
| 004 | EVEKEO ODT | AMPHETAMINE SULFATE | TABLET, ORALLY DISINTEGRATING;ORAL | 20MG | Yes | No |
| 005 | EVEKEO ODT | AMPHETAMINE SULFATE | TABLET, ORALLY DISINTEGRATING;ORAL | 2.5MG | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N209905-001 | EVEKEO ODT | AMPHETAMINE SULFATE | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | |
| N209905-002 | EVEKEO ODT | AMPHETAMINE SULFATE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | |
| N209905-003 | EVEKEO ODT | AMPHETAMINE SULFATE | 15MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | |
| N209905-004 | EVEKEO ODT | AMPHETAMINE SULFATE | 20MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | |
| N209905-005 | EVEKEO ODT | AMPHETAMINE SULFATE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2021-04-16 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N209905-001 | 10441554 | 2037-03-10 | Drug product | 2019-10-15 | |
| N209905-001 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 | |
| N209905-001 | 11896562 | 2037-03-10 | U-3299 | 2024-02-16 | |
| N209905-002 | 10441554 | 2037-03-10 | Drug product | 2019-10-15 | |
| N209905-002 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 | |
| N209905-002 | 11896562 | 2037-03-10 | U-3299 | 2024-02-16 | |
| N209905-003 | 10441554 | 2037-03-10 | Drug product | 2019-10-15 | |
| N209905-003 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 | |
| N209905-003 | 11896562 | 2037-03-10 | U-3299 | 2024-02-16 | |
| N209905-004 | 10441554 | 2037-03-10 | Drug product | 2019-10-15 | |
| N209905-004 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 | |
| N209905-004 | 11896562 | 2037-03-10 | U-3299 | 2024-02-16 | |
| N209905-005 | 10441554 | 2037-03-10 | Drug product | 2021-07-07 | |
| N209905-005 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N209905-001 | EVEKEO ODT | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209905-002 | EVEKEO ODT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209905-003 | EVEKEO ODT | 15MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209905-004 | EVEKEO ODT | 20MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209905-005 | EVEKEO ODT | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2021-04-16 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-001 | EVEKEO ODT | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-002 | EVEKEO ODT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-003 | EVEKEO ODT | 15MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-004 | EVEKEO ODT | 20MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-005 | EVEKEO ODT | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2021-04-16 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209905-001 | EVEKEO ODT | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209905-002 | EVEKEO ODT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209905-003 | EVEKEO ODT | 15MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209905-004 | EVEKEO ODT | 20MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209905-005 | EVEKEO ODT | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2021-04-16 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209905-001 | EVEKEO ODT | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209905-002 | EVEKEO ODT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209905-003 | EVEKEO ODT | 15MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209905-004 | EVEKEO ODT | 20MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209905-005 | EVEKEO ODT | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2021-04-16 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209905-001 | EVEKEO ODT | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209905-002 | EVEKEO ODT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209905-003 | EVEKEO ODT | 15MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209905-004 | EVEKEO ODT | 20MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209905-005 | EVEKEO ODT | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2021-04-16 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209905-001 | EVEKEO ODT | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209905-002 | EVEKEO ODT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209905-003 | EVEKEO ODT | 15MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209905-004 | EVEKEO ODT | 20MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209905-005 | EVEKEO ODT | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2021-04-16 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209905-001 | EVEKEO ODT | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209905-002 | EVEKEO ODT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209905-003 | EVEKEO ODT | 15MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209905-004 | EVEKEO ODT | 20MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209905-005 | EVEKEO ODT | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2021-04-16 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209905-001 | EVEKEO ODT | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209905-002 | EVEKEO ODT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209905-003 | EVEKEO ODT | 15MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209905-004 | EVEKEO ODT | 20MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2019-01-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209905-005 | EVEKEO ODT | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2021-04-16 | 5bbf6a4d5a75… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N209905-001 | 10441554 | 2037-03-10 | Drug product | 2019-10-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209905-001 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209905-001 | 11896562 | 2037-03-10 | U-3299 | 2024-02-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209905-002 | 10441554 | 2037-03-10 | Drug product | 2019-10-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209905-002 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209905-002 | 11896562 | 2037-03-10 | U-3299 | 2024-02-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209905-003 | 10441554 | 2037-03-10 | Drug product | 2019-10-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209905-003 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209905-003 | 11896562 | 2037-03-10 | U-3299 | 2024-02-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209905-004 | 10441554 | 2037-03-10 | Drug product | 2019-10-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209905-004 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209905-004 | 11896562 | 2037-03-10 | U-3299 | 2024-02-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209905-005 | 10441554 | 2037-03-10 | Drug product | 2021-07-07 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209905-005 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-001 | 10441554 | 2037-03-10 | Drug product | 2019-10-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-001 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-001 | 11896562 | 2037-03-10 | U-3299 | 2024-02-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-002 | 10441554 | 2037-03-10 | Drug product | 2019-10-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-002 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-002 | 11896562 | 2037-03-10 | U-3299 | 2024-02-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-003 | 10441554 | 2037-03-10 | Drug product | 2019-10-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-003 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-003 | 11896562 | 2037-03-10 | U-3299 | 2024-02-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-004 | 10441554 | 2037-03-10 | Drug product | 2019-10-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-004 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-004 | 11896562 | 2037-03-10 | U-3299 | 2024-02-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-005 | 10441554 | 2037-03-10 | Drug product | 2021-07-07 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209905-005 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209905-001 | 10441554 | 2037-03-10 | Drug product | 2019-10-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209905-001 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209905-001 | 11896562 | 2037-03-10 | U-3299 | 2024-02-16 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209905-002 | 10441554 | 2037-03-10 | Drug product | 2019-10-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209905-002 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209905-002 | 11896562 | 2037-03-10 | U-3299 | 2024-02-16 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209905-003 | 10441554 | 2037-03-10 | Drug product | 2019-10-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209905-003 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209905-003 | 11896562 | 2037-03-10 | U-3299 | 2024-02-16 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209905-004 | 10441554 | 2037-03-10 | Drug product | 2019-10-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209905-004 | 11160772 | 2037-03-10 | Drug product | 2021-12-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209905-004 | 11896562 | 2037-03-10 | U-3299 | 2024-02-16 | 6a471c1ec25d… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amphetamine Sulfate | AMPHETAMINE SULFATE | Amici Pharma, Inc. | e045dc28-e05d-4407-9d44-d0a11ca558e6 | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| Amphetamine Sulfate | AMPHETAMINE SULFATE | Granules Pharmaceuticals Inc. | 26dbad66-13c4-4906-88b3-ab7ee191466c | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| Amphetamine Sulfate | AMPHETAMINE SULFATE | Bryant Ranch Prepack | b94e2562-fd19-455f-ac10-2cc24302d27a | 2026-03-30 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| Amphetamine Sulfate | AMPHETAMINE SULFATE | Bryant Ranch Prepack | 920f99f4-ab78-4eed-9d80-08a2ebd0b769 | 2026-03-30 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| AMPHETAMINE SULFATE | AMPHETAMINE SULFATE | Bryant Ranch Prepack | 9817a519-fdb0-474a-92f4-2e485c9cb047 | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| Amphetamine Sulfate | AMPHETAMINE SULFATE | Epic Pharma LLC | 432db708-91b7-4802-88c3-ceef597b91da | 2025-12-17 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| Amphetamine Sulfate | AMPHETAMINE SULFATE | Wilshire Pharmaceuticals, Inc. | 91add2e3-8359-47dc-b79f-197d36b02819 | 2025-10-24 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| Evekeo | AMPHETAMINE SULFATE | Azurity Pharmaceuticals, Inc. | f469fb38-0380-4621-9db3-a4f429126156 | 2025-10-10 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| Amphetamine Sulfate | AMPHETAMINE SULFATE | Bryant Ranch Prepack | 674940ec-1714-4e41-b471-2a8c8a6c5ade | 2025-08-18 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| Amphetamine Sulfate | AMPHETAMINE SULFATE | Bryant Ranch Prepack | c972a6a4-a96c-4d70-b4c4-eef9e990abb4 | 2025-08-18 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| AMPHETAMINE SULFATE | AMPHETAMINE SULFATE | Solco Healthcare US, LLC | 89c5b52f-3c2a-41d5-8624-9ee51c512c72 | 2025-05-15 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| AMPHETAMINE SULFATE | AMPHETAMINE SULFATE | Bryant Ranch Prepack | 9eb84b3c-2147-42dd-8053-6afd1a88b0c1 | 2025-02-10 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| AMPHETAMINE SULFATE | AMPHETAMINE SULFATE | Bryant Ranch Prepack | 3ad894e3-78a7-4e3b-80d1-1a925fb6d9e3 | 2024-04-05 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| AMPHETAMINE SULFATE | AMPHETAMINE SULFATE | Bryant Ranch Prepack | 698171ee-4328-476a-b71c-58aa6dc93b23 | 2024-04-05 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| AMPHETAMINE SULFATE | AMPHETAMINE SULFATE | Bryant Ranch Prepack | c00bbade-3dc8-422b-8cff-f85db408bdfc | 2024-04-02 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| Amphetamine Sulfate | AMPHETAMINE SULFATE | Aurolife Pharma, LLC | 20735c2e-6304-425f-a4e4-584f6f90d6a0 | 2024-01-29 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| AMPHETAMINE SULFATE | AMPHETAMINE SULFATE | Bryant Ranch Prepack | ad4ce013-331b-4359-898f-bac97d64874f | 2024-01-25 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| AMPHETAMINE SULFATE | AMPHETAMINE SULFATE | Bryant Ranch Prepack | 7f16dd18-bf30-41ef-8981-932da5df0951 | 2024-01-25 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| AMPHETAMINE SULFATE | AMPHETAMINE SULFATE | Lannett Company, Inc. | 85a015a7-a1a0-4b04-8bc4-7aacd0c84742 | 2024-01-19 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
| AMPHETAMINE SULFATE | AMPHETAMINE SULFATE | Bryant Ranch Prepack | 8f9341fc-4b95-4556-a51a-ea972fa6fccc | 2024-01-09 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 24338-031 | Evekeo ODT | AMPHETAMINE SULFATE | Arbor Pharmaceuticals | NDA | Current |
| 24338-031 | Evekeo ODT | AMPHETAMINE SULFATE | Arbor Pharmaceuticals | NDA | Current |
| 24338-031 | Evekeo ODT | AMPHETAMINE SULFATE | Azurity Pharmaceuticals, Inc. | NDA | Current |
| 24338-031 | Evekeo ODT | AMPHETAMINE SULFATE | Arbor Pharmaceuticals | NDA | Current |
| 24338-031 | Evekeo ODT | AMPHETAMINE SULFATE | Azurity Pharmaceuticals, Inc. | NDA | Current |
| 24338-031 | Evekeo ODT | AMPHETAMINE SULFATE | Arbor Pharmaceuticals | NDA | Current |
| 24338-033 | Evekeo ODT | AMPHETAMINE SULFATE | Arbor Pharmaceuticals | NDA | Current |
| 24338-033 | Evekeo ODT | AMPHETAMINE SULFATE | Arbor Pharmaceuticals | NDA | Current |
| 24338-033 | Evekeo ODT | AMPHETAMINE SULFATE | Azurity Pharmaceuticals, Inc. | NDA | Current |
| 24338-033 | Evekeo ODT | AMPHETAMINE SULFATE | Arbor Pharmaceuticals | NDA | Current |
| 24338-033 | Evekeo ODT | AMPHETAMINE SULFATE | Azurity Pharmaceuticals, Inc. | NDA | Current |
| 24338-033 | Evekeo ODT | AMPHETAMINE SULFATE | Arbor Pharmaceuticals | NDA | Current |
| 24338-035 | Evekeo ODT | AMPHETAMINE SULFATE | Arbor Pharmaceuticals | NDA | Current |
| 24338-035 | Evekeo ODT | AMPHETAMINE SULFATE | Arbor Pharmaceuticals | NDA | Current |
| 24338-035 | Evekeo ODT | AMPHETAMINE SULFATE | Azurity Pharmaceuticals, Inc. | NDA | Current |
| 24338-035 | Evekeo ODT | AMPHETAMINE SULFATE | Arbor Pharmaceuticals | NDA | Current |
| 24338-035 | Evekeo ODT | AMPHETAMINE SULFATE | Azurity Pharmaceuticals, Inc. | NDA | Current |
| 24338-035 | Evekeo ODT | AMPHETAMINE SULFATE | Arbor Pharmaceuticals | NDA | Current |
| 24338-037 | Evekeo ODT | AMPHETAMINE SULFATE | Arbor Pharmaceuticals | NDA | Current |
| 24338-037 | Evekeo ODT | AMPHETAMINE SULFATE | Arbor Pharmaceuticals | NDA | Current |
| 24338-037 | Evekeo ODT | AMPHETAMINE SULFATE | Azurity Pharmaceuticals, Inc. | NDA | Current |
| 24338-037 | Evekeo ODT | AMPHETAMINE SULFATE | Arbor Pharmaceuticals | NDA | Current |
| 24338-037 | Evekeo ODT | AMPHETAMINE SULFATE | Azurity Pharmaceuticals, Inc. | NDA | Current |
| 24338-037 | Evekeo ODT | AMPHETAMINE SULFATE | Arbor Pharmaceuticals | NDA | Current |
| 24338-045 | Evekeo ODT | AMPHETAMINE SULFATE | Arbor Pharmaceuticals | NDA | Current |
| 24338-045 | Evekeo ODT | AMPHETAMINE SULFATE | Arbor Pharmaceuticals | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 75796 | SUPPL | 2023-10-17 |
| 75795 | SUPPL | 2023-10-17 |
| 75766 | SUPPL | 2023-10-16 |
| 72227 | SUPPL | 2022-10-03 |
| 72226 | SUPPL | 2022-10-03 |
| 72210 | SUPPL | 2022-10-03 |
| 70331 | SUPPL | 2022-03-01 |
| 70330 | SUPPL | 2022-03-01 |
| 70292 | SUPPL | 2022-02-28 |
| 67115 | SUPPL | 2021-04-19 |
| 67099 | SUPPL | 2021-04-19 |
| 59284 | ORIG | 2019-07-09 |
| 57545 | ORIG | 2019-02-13 |
| 57390 | ORIG | 2019-01-31 |
| 57389 | ORIG | 2019-01-31 |